<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01971099</url>
  </required_header>
  <id_info>
    <org_study_id>TTM1</org_study_id>
    <nct_id>NCT01971099</nct_id>
  </id_info>
  <brief_title>Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder</brief_title>
  <official_title>Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoactive Sexual Desire Disorder (HSDD) is the most prevalent female sexual dysfunction in
      society and is strongly linked to the quality of life of women. The androgen hormones decline
      over age in the premenopausal period, which occurs around 20 years. Tribulus terrestris is a
      plant native to India, recommended in the treatment of infertility, low libido and impotence.
      Its main active ingredient is the protodioscin, which has been attributed to an increase in
      testosterone levels and improved sexual function. The aim of this study is to evaluate the
      effects of Tribulus Terrestris in premenopausal women with HSDD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sexual Desire</measure>
    <time_frame>120 days</time_frame>
    <description>we will use the &quot;Quotient Sexual - Version Feminine (QS-F) brazilian questionary to make the evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum levels of prolactin and thyroid-stimulating hormone (TSH)</measure>
    <time_frame>120 days</time_frame>
    <description>blood test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>serum levels of testosterone and sex hormone-binding globulin (SHBG)</measure>
    <time_frame>120 days</time_frame>
    <description>blood test</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Hypoactive Sexual Desire Disfunction</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients will use placebo for 120 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tribulus Terrestris</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will use Tribulus terrestris (750 mg/day) during 120 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tribulus terrestris</intervention_name>
    <description>patients will use 750mg/day of tribulus terrestris</description>
    <arm_group_label>Tribulus Terrestris</arm_group_label>
    <other_name>tribulus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>patients will take one pill a day (the same shape of the drug)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  regular menstrual cycle

          -  with no use of hormonal contraception within the last 3 months

          -  without any medication, drugs or alcohol.

          -  Healthy patients without systemic or psychiatric disease

        Exclusion Criteria:

          -  Patients with amenorrhea and/or pregnant.

               -  Patients who underwent bilateral oophorectomy.

               -  Patient smoker (10 cigarettes per day).

               -  Patients with blood pressure &gt; 160/90 mm Hg.

               -  Patient with breast or endometrial carcinoma.

               -  Patients with a history of myocardial infarction.

               -  Patient with Diabetes.

               -  Patient with vaginal bleeding from any source.

               -  Patients with hepatic injury.

               -  Patients with active thrombophlebitis or thromboembolic disorders recent

               -  Patients with interpersonal relationship problems with your relationship or
                  partner

               -  Patients with sexual problems from your partner
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Selmo Geber, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clinicas - Universidade Federal de Minas Gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2013</study_first_submitted>
  <study_first_submitted_qc>October 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2013</study_first_posted>
  <last_update_submitted>January 13, 2016</last_update_submitted>
  <last_update_submitted_qc>January 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Selmo Geber</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sexual function</keyword>
  <keyword>hypoactive</keyword>
  <keyword>desire</keyword>
  <keyword>androgens</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypokinesia</mesh_term>
    <mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

